Why the study?
Outcomes of AF ablation vary across centers, and most data derive from Western countries while data from Southeast Asian countries are lacking.
Does radiofrequency ablation improve freedom from atrial fibrillation in Thai patients undergoing their first ablation?
Does radiofrequency ablation improve freedom from atrial fibrillation in Thai patients undergoing their first ablation?
Radiofrequency ablation for atrial fibrillation in a Thai cohort demonstrated a 73% success rate at 12 months, which declined to 55% at 36 months, with PVI showing higher success rates than CFAE ablation.
Supports PVI as initial strategy in Thai AF patients; leaves open need for randomized confirmation of durability.
BACKGROUND: The result of atrial fibrillation (AF) ablation varies across centers. Most data are derived from the Western world, while data from Southeast Asian countries are lacking. We aimed to investigate the outcomes of AF ablation in Thailand. METHOD: We performed a retrospective analysis of patients who underwent AF ablation in a tertiary care center, between the years 2006-2020. Details of AF ablation, including pulmonary vein isolation (PVI), and complex fractionated atrial electrogram (CFAE) ablation, were classified. The success rate of AF ablation is determined by freedom from AF beyond 3 months blanking period. Combined success rate of AF ablation was reported along with the success rate of each technique (PVI, CFAE, and combine PVI plus CFAE). RESULT: We identified a total of 171 patients who underwent the first AF ablation. Ninety-four (55%) patients went through PVI, 55 (32%) patients for CFAE ablation, and 22 (13%) patients for PVI plus CFAE ablation. Overall freedom from AF was 73% at 12 months, 66% at 24 months, and 55% at 36 months. The success rate of PVI was 79% at 12 months, 74% at 24 months, and 59% at 36 months. The success rate of CFAE ablation was 63% at 12 months, 51% at 24 months, and 47% at 36 months. CONCLUSION: Catheter ablation of AF is proven safe and effective in Thai population.
No takes yet. Share an insight, caveat, or question.
Tokavanich et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: